Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jinghua He

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
The Prostate|April 30, 2024
Differences in real-world outcomes by risk classification for localized prostate cancer patients after radiation therapyLawrence Karsh, Shawn Du, Jinghua He, et al.
Pharmacoepidemiology and Drug Safety|May 20, 2016
Identification of impaired fasting glucose, healthcare utilization and progression to diabetes in the UK using the Clinical Practice Research Datalink (CPRD)Jin-Liern Hong, Ann Marie McNeill, Jinghua He, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|October 26, 2021
Healthcare Resource Utilization and Costs of Rivaroxaban Versus Warfarin Among Nonvalvular Atrial Fibrillation Patients with Obesity and DiabetesMatthew R Weir, Yen-Wen Chen, Jinghua He, et al.
Journal of Diabetes and Its Complications|September 20, 2021
Effectiveness and safety of rivaroxaban versus warfarin among nonvalvular atrial fibrillation patients with obesity and diabetesMatthew R Weir, Yen-Wen Chen, Jinghua He, et al.
Clinical Genitourinary Cancer|May 9, 2018
Survival Rates and Health Care Costs for Patients With Advanced Bladder Cancer Treated and Untreated With ChemotherapyKyle Flannery, Xiting Cao, Jinghua He, et al.
Journal of Traditional Chinese Medicine = Chung I Tsa Chih Ying Wen Pan|March 8, 2016
Synergetic effects of aqueous extracts of Fuzi (Radix Aconiti Lateralis Preparata) and Tubeimu (Rhizoma Bolbostemmatis) on MDA-MB-231 and SKBR3 cellsDan Chen, Rui Cao, Jinghua He, et al.
The Journal of International Medical Research|January 13, 2022
Interleukin-17 and vascular endothelial growth factor: new biomarkers for the diagnosis of papillary thyroid carcinoma in patients with Hashimoto's thyroiditisShuiping Li, Shilin Li, Min Lin, et al.
Oncology and Therapy|May 17, 2022
Healthcare Costs of Multiple Myeloma Patients with Four or More Prior Lines of Therapy, Including Triple-Class Exposure in the United StatesSundar Jagannath, Nedra Joseph, Jinghua He, et al.
Oncology and Therapy|October 25, 2021
Healthcare Costs Incurred by Patients with Multiple Myeloma Following Triple Class Exposure (TCE) in the USSundar Jagannath, Nedra Joseph, Jinghua He, et al.
European Journal of Pharmacology|April 4, 2019
Dioscin inhibits intimal hyperplasia in rat carotid artery balloon injury model through inhibition of the MAPK-FoxM1 pathwayTianfei Fan, Jinghua He, Yongqiang Yin, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
The Prostate|April 30, 2024
Differences in real-world outcomes by risk classification for localized prostate cancer patients after radiation therapyLawrence Karsh, Shawn Du, Jinghua He, et al.
Pharmacoepidemiology and Drug Safety|May 20, 2016
Identification of impaired fasting glucose, healthcare utilization and progression to diabetes in the UK using the Clinical Practice Research Datalink (CPRD)Jin-Liern Hong, Ann Marie McNeill, Jinghua He, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|October 26, 2021
Healthcare Resource Utilization and Costs of Rivaroxaban Versus Warfarin Among Nonvalvular Atrial Fibrillation Patients with Obesity and DiabetesMatthew R Weir, Yen-Wen Chen, Jinghua He, et al.
Journal of Diabetes and Its Complications|September 20, 2021
Effectiveness and safety of rivaroxaban versus warfarin among nonvalvular atrial fibrillation patients with obesity and diabetesMatthew R Weir, Yen-Wen Chen, Jinghua He, et al.
Clinical Genitourinary Cancer|May 9, 2018
Survival Rates and Health Care Costs for Patients With Advanced Bladder Cancer Treated and Untreated With ChemotherapyKyle Flannery, Xiting Cao, Jinghua He, et al.
Journal of Traditional Chinese Medicine = Chung I Tsa Chih Ying Wen Pan|March 8, 2016
Synergetic effects of aqueous extracts of Fuzi (Radix Aconiti Lateralis Preparata) and Tubeimu (Rhizoma Bolbostemmatis) on MDA-MB-231 and SKBR3 cellsDan Chen, Rui Cao, Jinghua He, et al.
The Journal of International Medical Research|January 13, 2022
Interleukin-17 and vascular endothelial growth factor: new biomarkers for the diagnosis of papillary thyroid carcinoma in patients with Hashimoto's thyroiditisShuiping Li, Shilin Li, Min Lin, et al.
Oncology and Therapy|May 17, 2022
Healthcare Costs of Multiple Myeloma Patients with Four or More Prior Lines of Therapy, Including Triple-Class Exposure in the United StatesSundar Jagannath, Nedra Joseph, Jinghua He, et al.
Oncology and Therapy|October 25, 2021
Healthcare Costs Incurred by Patients with Multiple Myeloma Following Triple Class Exposure (TCE) in the USSundar Jagannath, Nedra Joseph, Jinghua He, et al.
European Journal of Pharmacology|April 4, 2019
Dioscin inhibits intimal hyperplasia in rat carotid artery balloon injury model through inhibition of the MAPK-FoxM1 pathwayTianfei Fan, Jinghua He, Yongqiang Yin, et al.
Pageof 6